LBPH - Longboard Pharmaceuticals, Inc.

QQQ $ 471.60 $ -1.46 (-0.31 %)

DIA $ 416.42 $ -0.53 (-0.13 %)

SPY $ 561.55 $ 0.09 (0.02 %)

TLT $ 101.11 $ 0.48 (0.48 %)

GLD $ 238.63 $ 0.03 (0.01 %)

Previous Close

$ 34.32

Open

$ 34.63

Bid

$ 31.53 x 200

Ask

-- x --

Day's Range

$ 30.89 - $ 34.63

52 Week Range

$ 3.60 - $ 40.48

Volume

159,221

Average Volume

Market Cap

1.34B

Beta (5Y Monthly)

$ 0.19

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-01-2024	06-30-2024	10-Q
2	05-02-2024	03-31-2024	10-Q
3	03-12-2024	12-31-2023	10-K
4	11-02-2023	09-30-2023	10-Q
5	08-03-2023	06-30-2023	10-Q
6	05-09-2023	03-31-2023	10-Q
7	03-02-2023	12-31-2022	10-K
8	11-03-2022	09-30-2022	10-Q
9	08-04-2022	06-30-2022	10-Q
10	05-05-2022	03-31-2022	10-Q
11	03-03-2022	12-31-2021	10-K
12	11-04-2021	09-30-2021	10-Q
13	08-09-2021	06-30-2021	10-Q
14	05-10-2021	03-31-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Cantor Fitzgerald Reiterates Overweight on...
09/16/2024 15:56:34

Cantor Fitzgerald analyst Josh Schimmer reiterates Longboard Pharmaceuticals (NASDAQ:LBPH) with a Overweight and maintains $...

longboard-pharmaceuticals-boasts-high-value-epilepsy-assets-analyst-initiates-coverage

Longboard Pharmaceuticals Boasts High-Valu...
09/10/2024 18:13:01

Truist Securities initiated coverage on Longboard Pharmaceuticals, citing it as a CNS-focused biotech with high-value epilepsy ...

Truist Securities Initiates Coverage On Lo...
09/10/2024 10:57:43

Truist Securities analyst Joon Lee initiates coverage on Longboard Pharmaceuticals (NASDAQ:LBPH) with a Buy rating and annou...

Reported Sunday, Longboard Pharmaceuticals...
09/09/2024 07:51:53

Bexicaserin achieved an overall median seizure reduction of 57.7% in countable motor seizures over an approximate 9-month tre...

Longboard Pharmaceuticals To Present Data ...
08/26/2024 20:03:45

Evercore ISI Group Maintains Outperform on...
08/26/2024 14:58:27

Evercore ISI Group analyst Josh Schimmer maintains Longboard Pharmaceuticals (NASDAQ:LBPH) with a Outperform and maintains $...

HC Wainwright & Co. Reiterates Buy on Long...
08/22/2024 12:57:30

HC Wainwright & Co. analyst Patrick Trucchio reiterates Longboard Pharmaceuticals (NASDAQ:LBPH) with a Buy and maintains...

B. Riley Securities Maintains Buy on Longb...
08/05/2024 16:36:33

B. Riley Securities analyst Kalpit Patel maintains Longboard Pharmaceuticals (NASDAQ:LBPH) with a Buy and raises the price t...

Citigroup Maintains Buy on Longboard Pharm...
08/02/2024 16:11:39

Citigroup analyst David Hoang maintains Longboard Pharmaceuticals (NASDAQ:LBPH) with a Buy and raises the price target from ...

Cantor Fitzgerald Reiterates Overweight on...
08/02/2024 15:23:12

Cantor Fitzgerald analyst Josh Schimmer reiterates Longboard Pharmaceuticals (NASDAQ:LBPH) with a Overweight and maintains $...

Wedbush Maintains Outperform on Longboard ...
08/02/2024 13:19:55

Wedbush analyst Laura Chico maintains Longboard Pharmaceuticals (NASDAQ:LBPH) with a Outperform and lowers the price target ...

Longboard Pharmaceuticals Q2 2024 GAAP EPS...
08/01/2024 20:19:50

Longboard Pharmaceuticals (NASDAQ:LBPH) reported quarterly losses of $(0.56) per share which missed the analyst consensus estim...

HC Wainwright & Co. Reiterates Buy on Long...
08/01/2024 10:27:01

HC Wainwright & Co. analyst Patrick Trucchio reiterates Longboard Pharmaceuticals (NASDAQ:LBPH) with a Buy and maintains...

Baird Maintains Outperform on Longboard Ph...
07/11/2024 11:12:21

Baird analyst Joel Beatty maintains Longboard Pharmaceuticals (NASDAQ:LBPH) with a Outperform and raises the price target fr...

top-3-health-care-stocks-that-may-crash-this-quarter

Top 3 Health Care Stocks That May Crash Th...
07/03/2024 13:41:08

Citigroup Maintains Buy on Longboard Pharm...
07/02/2024 18:36:01

Citigroup analyst David Hoang maintains Longboard Pharmaceuticals (NASDAQ:LBPH) with a Buy and raises the price target from ...

Evercore ISI Group Maintains Outperform on...
07/02/2024 15:45:11

Evercore ISI Group analyst Josh Schimmer maintains Longboard Pharmaceuticals (NASDAQ:LBPH) with a Outperform and raises the ...

Longboard Pharmaceuticals Announces FDA Gr...
07/01/2024 13:03:11

U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for bexicaserin for the treatment of seizu...

Evercore ISI Group Maintains Outperform on...
06/20/2024 14:42:48

Evercore ISI Group analyst Josh Schimmer maintains Longboard Pharmaceuticals (NASDAQ:LBPH) with a Outperform and raises the ...

Cantor Fitzgerald Reiterates Overweight on...
06/20/2024 13:12:59

Cantor Fitzgerald analyst Josh Schimmer reiterates Longboard Pharmaceuticals (NASDAQ:LBPH) with a Overweight and maintains $...